Mahant A, Gualdron T, Herold B
Vaccines (Basel). 2024; 12(10).
PMID: 39460294
PMC: 11511495.
DOI: 10.3390/vaccines12101127.
Seyfizadeh N, Kalbermatter D, Imhof T, Ries M, Muller C, Jenner L
J Biomed Sci. 2024; 31(1):56.
PMID: 38807208
PMC: 11134845.
DOI: 10.1186/s12929-024-01045-2.
Liljeqvist J, Onnheim K, Tunback P, Eriksson K, Gorander S, Backstrom M
Antibodies (Basel). 2024; 13(2).
PMID: 38804308
PMC: 11130973.
DOI: 10.3390/antib13020040.
Zdziarski P, Gamian A
Biomedicines. 2024; 12(3).
PMID: 38540179
PMC: 10968319.
DOI: 10.3390/biomedicines12030566.
Slein M, Backes I, Garland C, Kelkar N, Leib D, Ackerman M
Cell Rep Med. 2024; 5(2):101417.
PMID: 38350452
PMC: 10897633.
DOI: 10.1016/j.xcrm.2024.101417.
Protective mechanisms of nonneutralizing antiviral antibodies.
Chandler T, Yang A, Otero C, Permar S, Caddy S
PLoS Pathog. 2023; 19(10):e1011670.
PMID: 37796829
PMC: 10553219.
DOI: 10.1371/journal.ppat.1011670.
Antibody attributes, Fc receptor expression, gestation and maternal SARS-CoV-2 infection modulate HSV IgG placental transfer.
Mahant A, Trejo F, Aguilan J, Sidoli S, Permar S, Herold B
iScience. 2023; 26(9):107648.
PMID: 37670782
PMC: 10475509.
DOI: 10.1016/j.isci.2023.107648.
Polyfunctional antibodies: a path towards precision vaccines for vulnerable populations.
Purcell R, Theisen R, Arnold K, Chung A, Selva K
Front Immunol. 2023; 14:1183727.
PMID: 37600816
PMC: 10433199.
DOI: 10.3389/fimmu.2023.1183727.
Dual impacts of a glycan shield on the envelope glycoprotein B of HSV-1: evasion from human antibodies and neurovirulence.
Fukui A, Maruzuru Y, Ohno S, Nobe M, Iwata S, Takeshima K
mBio. 2023; 14(4):e0099223.
PMID: 37366623
PMC: 10470582.
DOI: 10.1128/mbio.00992-23.
Prolonged Preterm Rupture of Membranes Associated with Neonatal Disseminated Herpes Simplex Virus Type 1 at Birth: Is There a Role for Preemptive Test and Treat Strategies in High-Risk Populations?.
Estrada F, Mahant A, Guerguis S, Sy S, Lu C, Reznik S
J Pediatric Infect Dis Soc. 2023; 12(4):246-247.
PMID: 37001048
PMC: 10146922.
DOI: 10.1093/jpids/piac131.
A non-neutralizing glycoprotein B monoclonal antibody protects against herpes simplex virus disease in mice.
Kuraoka M, Aschner C, Windsor I, Mahant A, Garforth S, Kong S
J Clin Invest. 2022; 133(3.
PMID: 36454639
PMC: 9888390.
DOI: 10.1172/JCI161968.
Maternally transferred mAbs protect neonatal mice from HSV-induced mortality and morbidity.
Backes I, Byrd B, Slein M, Patel C, Taylor S, Garland C
J Exp Med. 2022; 219(12).
PMID: 36156707
PMC: 9516843.
DOI: 10.1084/jem.20220110.
Monoclonal antibody therapy of herpes simplex virus: An opportunity to decrease congenital and perinatal infections.
Backes I, Leib D, Ackerman M
Front Immunol. 2022; 13:959603.
PMID: 36016956
PMC: 9398215.
DOI: 10.3389/fimmu.2022.959603.
Failure of Herpes Simplex Virus Glycoprotein D Antibodies to Elicit Antibody-Dependent Cell-Mediated Cytotoxicity: Implications for Future Vaccines.
Mahant A, Guerguis S, Blevins T, Cheshenko N, Gao W, Anastos K
J Infect Dis. 2022; 226(9):1489-1498.
PMID: 35834278
PMC: 10205893.
DOI: 10.1093/infdis/jiac284.
Alphaherpesvirus Vaccines.
Aschner C, Herold B
Curr Issues Mol Biol. 2020; 41:469-508.
PMID: 32963118
PMC: 8211365.
DOI: 10.21775/cimb.041.469.
HVEM signaling promotes protective antibody-dependent cellular cytotoxicity (ADCC) vaccine responses to herpes simplex viruses.
Aschner C, Loh L, Galen B, Delwel I, Jangra R, Garforth S
Sci Immunol. 2020; 5(50).
PMID: 32817296
PMC: 7673108.
DOI: 10.1126/sciimmunol.aax2454.
Newcastle Disease Virus as a Vaccine Vector for 20 Years: A Focus on Maternally Derived Antibody Interference.
Hu Z, Ni J, Cao Y, Liu X
Vaccines (Basel). 2020; 8(2).
PMID: 32422944
PMC: 7349365.
DOI: 10.3390/vaccines8020222.
Model of vaccine efficacy against HSV-2 superinfection of HSV-1 seropositive mice demonstrates protection by antibodies mediating cellular cytotoxicity.
Aschner C, Knipe D, Herold B
NPJ Vaccines. 2020; 5(1):35.
PMID: 32411398
PMC: 7206093.
DOI: 10.1038/s41541-020-0184-7.
Vaccines to prevent genital herpes.
Egan K, Hook L, LaTourette P, Desmond A, Awasthi S, Friedman H
Transl Res. 2020; 220:138-152.
PMID: 32272093
PMC: 7293938.
DOI: 10.1016/j.trsl.2020.03.004.
Trivalent Glycoprotein Subunit Vaccine Prevents Neonatal Herpes Simplex Virus Mortality and Morbidity.
Patel C, Taylor S, Mehrbach J, Awasthi S, Friedman H, Leib D
J Virol. 2020; 94(11).
PMID: 32188735
PMC: 7269440.
DOI: 10.1128/JVI.02163-19.